MHY-2245

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameMHY-2245
Drug Alias NameMHY-2245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSungkyunkwan University
China Registration ClassN/A

Develop Information

Active CompaniesSungkyunkwan University
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A